this quarter the british swedish company expects to deliver $30000000.00 doses a quarter less than the already reduced figure it promised last month it's a 3rd of the amount the e.u. originally signed up for and cons as another blow to the blocks vaccine rollout however it closely follows news that europe's medicines regulator has approved the single shot johnson and johnson vaccine for. our financial correspondent chelsea delaney has more from frankfurt. it's been one setback after another for the e this vaccination campaign and the latest news from astra zeneca indicates that isn't going to be changing anytime soon the u.k. company is now expecting to fall well short of its pledge deliveries to the e.u. in both the 1st and the 2nd quarter so stretching into the summer as well we've seen multiple european countries actually temporarily suspend the use of the astra zeneca shot over melting concerns about the safety of the vaccine but the big hope for europe had been at the johnson and johnson vaccine which was approved this week but already european officials have tried to temper some

amount of coronavirus vaccines of plants to supply to the european union this quarter the british swedish company expects to deliver $30000000.00 doses a quarter less than the already reduced figure it promised last month it's a 3rd of the amount the originally signed up for and comes as another blow for the box vaccine rollout however closely follows news that europe's medicines regulator has approved the single shot johnson and johnson vaccine for use. that's got more in this form our financial correspondent chelsea delaney in frankfurt chelsea successful covert vaccinations are key for countries and economies to go back to normal now they has been heavy criticism of the pace of the e.u. vaccine rollout is there any indication that will change soon. well there really isn't a lot of hope on the horizon for the e.u. vaccination effort the astra zeneca news is a major blow and astra zeneca is cutting not only their forecast for this 1st quarter but also they're expected to deliver about half of what they had pledged for the 2nd quarter as well so we will see a major shortfall of that crucial vacci

and astra zeneca the british swedish company in the last couple of hours we've heard an erroneous e.u. officials saying that the u.k. is not to blame the e.u. is not to blame clearly pointing the finger at the company for not meeting can crush contractual obligations now we know that prime minister boris johnson in the next couple of days will be phoning his counterparts in the people like president michel of france and chancellor merkel he is also going to talk to is it up on the lion head of the european commission who at the weekend floated the possibility of the european union imposing what amounts to an export ban on all vaccinations from the e.u. from that bloc to the u.k. now everyone saying that they don't want that to happen but the. noises out of brussels today are that they really do want astra zeneca to start committing to what it's promised the company says it's all because the e.u. signed contracts much later than the u.k. did last year and of course we know what's happened since the year u.k. has steamed ahead with its vaccination program compared to the e.u. which is s

amount of corona virus vaccines have plans to supply to the european union disc water the british swedish company expects deliver $30000000.00 doses a quarter less than the already reduced figure it promised last month that's a 3rd of the amount that you urging you signed up for it comes as another blow to the blocks vaccine rollout. now supplying the grass for the fifo world cup pitch a dream job for those in the sports and recreational turf industry but dutch company hendrick scouse has canceled their deal for the upcoming event in qatar that's following media reports of over 6 and a half 1000 deaths of migrant workers on construction sites there. grass grown in the netherlands is used in football stadiums around the world the 2022 world cup was set to be played on sod from hendricks grass oden but the company has cancelled the deal there pointing to the staggering number of fatalities among workers building up the cups infrastructure. a report in the guardian newspaper startled the company it stated that more than 65100 guest workers have died since the cup was awarded to qatar 10 years ago mo

it is having problems with pharmaceutical companies the route with esther astra zeneca the british swedish company failing to deliver doses says the e.u. and that is why it is looking at this measure it is there as i say controversial some leaders and countries italy france among them support the measure they say it's a good idea it is necessary those are countries that are really battling a 3rd wave in many regions other countries the netherlands island they're more cautious they don't want to see the e.u. employed in any sort of vaccine war and so many politicians are saying look a lot of this is perhaps just a talk by the e.u. commission to try and ramp up the rhetoric to force pharmaceutical companies to deliver the doses that they were contracted to do and president biden is addressing the summit soon what's that going to be about. yes a special guest if you like the u.s. president joe biden addressing the e.u. summit he was invited by the head of the you council osho michelle to take parts and it is being seen by both sides really as an effort to revitalize relations between the united state

she used the british swedish company astra zeneca as an example she said they have only delivered 30 percent of the $90000000.00 doses the they've been contracted to deliver in the 1st quarter of this year she said that was obviously unexceptable and that the e.u. expected a lot more what she didn't do though was say what would happen if these pharmaceutical companies complete continue to lag behind in their delivery of doses now the u. commission had proposed before going into this summit to put curbs on exports of vaccines abroad but it seems at the end of the summit i mean it was clear the e.u. leaders simply didn't back this proposal all the way they were always very divided on this plan which was seen as quite controversial on one side countries like italy and france fully supported it saying that yes pharmaceutical companies should not be able to export vaccine doses whilst they haven't delivered the doses expected in the e.u. imagine micro the french president was certainly very vocal in his press conference after the summit on thursday on the other hand countries like the net

this quarter the british swedish company expects to deliver $30000000.00 doses a quarter less than the already reduced figure it promised last month it's a 3rd of the amount the e.u. originally signed up for and cons as another blow to the blocks vaccine rollout however it closely follows news that europe's medicines regulator has approved the single shot johnson and johnson vaccine for. our financial correspondent chelsea laney has more from frankfurt. it's been one setback after another for the eva sox nation campaign and the latest news from astra zeneca indicates that isn't going to be changing anytime soon the u.k. company is now expecting to fall well short of its pledge deliveries so the e.u. and both the 1st and the 2nd quarter so stretching into the summer as well we've seen multiple european countries actually temporarily suspend the use of the astra zeneca shot over mounting concerns about the safety of the vaccine the big hope for europe ben johnson and johnson vaccine which was approved this week but already european officials have tried to temper some of this optimism her

and astra zeneca the british swedish company in the last couple of hours we've heard and around us e.u. officials saying that the u.k. is not to blame the e.u. is not to blame clearly pointing the finger at the company for not meeting can catch contractual obligations now we know that prime minister boris johnson in the next couple of days will be phoning his counterparts in the people like president michel of france and chancellor merkel he is also going to talk to is of on the line head of the european commission who at the weekend floated the possibility of the european union imposing what amounts to an export ban on all vaccinations from the e.u. from that bloc to the u.k. now everyone is saying that they don't want that to happen but the. noises out of brussels today are that they really do want astra zeneca to start committing to what its promise the company says it's all because the e.u. signed contracts much later than the u.k. did last year and of course we know what's happened since the u.k. has seen the head with its vaccination program compared to the e.u. which is stalled

pandemic yes and no many companies have benefited from both state funding as well as cash injections from foundations. both u.s. pharma giant johnson and johnson and swedish british company astra zeneca received one and a half $1000000000.00 in state funds both committed to selling their vaccines at cost price you know other words not to make a profit from them by own take 5 years or got about half a 1000000000 in state funds pfizer says private investors have taken on most of the risk and are now being rewarded accordingly so far as a buying take vaccine is expected to have a profit margin of up to 30 percent this year alone that would amount to some $4000000000.00. now 1 august other opponent to the idea of scrapping vaccine patents are the patent holders and sells pharma companies earlier we spoke to thomas quiney he's the head of the international federation of pharmaceutical manufacturers and associations here is what he had to say. i am by to jan and of making more progress at the summit which i just mentioned which was hosted by chance in my eyes we all from developing country met vaccine manufacturers and i remember as we committed to further expand acces

that they deliver the doses that were contracted and expected she's used the example of the british swedish company astra zeneca saying that they have only delivered a 3rd of the 90000000 doses that they were expected to deliver in the 1st quarter of the year that is simply not good enough now what the had wanted to do was try and persuade member states to back a proposal to curb exports of vaccines abroad because the commission says while these pharmaceutical companies are sending doses abroad doses are being produced in the e.u. they should actually be keeping them in the e.u. and delivering them to the e.u. as contract is well unfortunately for the commission member states and he didn't back that proposal some countries like france and italy thought it was a very good idea they want to send a strong message to pharmaceutical companies to do more other countries like the netherlands and belgium certainly a lot more cautious saying that they want to keep this sort of vaccine supply chain open and this is in keeping with evaluate nevertheless governments in the e.u. are under a lot of pressure beca

this quarter the british swedish company expects to deliver $30000000.00 doses a quarter less than the already reduced figure it promised last month it's a 3rd of the amount of the e.u. originally signed up for and columns as another blow to the blocks vaccine rollout . our financial correspondent chelsea delaney has more from frankfurt. it's been one setback after another for the e.u. stocks a nation campaign and the latest news from astra zeneca indicates that isn't going to be changing anytime soon the u.k. company is now expecting to fall well short of its pledge deliveries to the e.u. in both the 1st and the 2nd quarter so stretching into the summer as well we've seen multiple european countries actually temporarily suspend the use of the astra zeneca shot over mounting concerns about the safety of the vaccine the big hope for europe have been the johnson and johnson vaccine which was approved this week but already european officials have tried to temper some of this optimism here in germany the health minister has warned he likely won't get any distribution we won't get any shots

federal health officials said the british-swedish company may have included outdated information in itsomplete view of the efficacy. astrazeneca said it will be updating its trial data in 24 hours. dr. fauci called the situation unfortunate for an otherwise effective vaccine. >> you know, this is really what you call an unforced error. because the fact is this is very likely a very good vaccine. and this kind of thing does, as you say, do nothing but really cast some doubt about the vaccines and maybe contribute to the hesitancy. it was not necessary. if you look, the data really are quite good. when they put it into the press release, it wasn't completely accurate. so we have to keep essentially trying as hard as we can to get people to understand that there are safeguards in place. >> joining me now is co-director for vaccine development at texas children's hospital, dr. peter hotez. dr. hotez, i just find this to be incredible that astrazeneca continues to have these issues on messaging. when messaging is so critically important when you're trying to get people to take your vaccine.

pandemic yes and no many companies have benefited from both state funding as well as cash injections from foundations. both u.s. pharma giant johnson and johnson and swedish british company astra zeneca received one and a half $1000000000.00 in state funds both then committed to selling their vaccines at cost price you know other words not to make a profit from them by own take fires or got about half a 1000000000 in state funds pfizer's says private investors have taken on most of the risk and are now being rewarded accordingly so far as a biotech vaccine is expected to have a profit margin of up to 30 percent this year alone that would amount to some $4000000000.00. now one obvious other opponent to the idea of scrapping vaccine patents are the patent holders and selves pharma companies earlier we spoke to thomas quiney he's the head of the international federation of pharmaceutical manufacturers and associations here is what he adds. i am by to jan and of making more progress at the summit which i just mentioned which was harvested by chance in my eyes we all from developing country met vaccine manufacturers and i remember as we committed to further expand acc

pandemic yes and no many companies have benefited from both state funding as well as cash injections from foundations. both u.s. pharma giant johnson and johnson and swedish british company astra zeneca received one and a half $1000000000.00 in state funds both been committed to selling their vaccines at cost price you know other words not to make a profit from them by on take 5 years or got about half a 1000000000 in state funds pfizer says private investors have taken on most of the risk and are now being rewarded accordingly so far as the buying take back seen is expected to have a profit margin of up to 30 percent this year alone that would amount to some $4000000000.00. or more and thomas 20 is the head of the international federation of pharmaceutical manufacturers and associations welcome to d w thomas thanks for making time for us is a 30 percent profit margin ethically justifiable when prices for vaccines like that could prevent hundreds of millions of lives being saved. when you look at what's happened over the last 10 moms i think it's 1st important to acknowledge the amazing progress made is literally from 0 are to billions of dollars is we see light

italy blocking the export of 250,000 doses of the astrazeneca jab, which, of course is a british swedish companydeal on christmas eve last year, this christmas present that was served up to everyone, but the idea of a season of goodwill continuing into 2021, i think that sort of notion is long gone. stay with us on 0utside source. in myamar, a dozen burmese police officers flee to india after being told to shoot protestors. they have the spoken exclusively to the bbc. women have borne a bigger burden of childcare, home—schooling and housework than men over the course of the pandemic — according to new analysis of data from office for national statistics. it also suggests women have experienced significantly poorer levels of personal well—being and are more likely to have been furloughed. 0ur health correspondent, catherine burns, has been hearing from some women about the effect the pandemic has had on them. it's an experience that really allows feelings of anxiety, loneliness, to fester. we've been having tojuggle home—schooling our five—year—old and looking after our 18—month—old. it was bruta

of the large pharmaceutical companies to secure big markets good prices big profits going to the people they have the most control over as for zeneca is a british and swedish company it has special relationships with those politicians and so you shouldn't be surprised that the u.k. has more astra zeneca than the rest of europe this is unfortunately the way the system works this is a global pandemic it needs a global response and what we have instead is different companies lobbying with different governments to get it then it is astra zeneca promised hundreds of millions of doses to be delivered and have since then been cutting back on the number of those says they deliver different amounts have been cut back one country to another which of course spoke suspicions of one country getting advantages over another europe is an attempt to get together a lots of different countries this is the worst possible way being driven between them and the other factor is that there's no nice way to say this the chinese and all that societies showed us early in the cold that pandemics shot everything down tight yes in the short run that has economic costs but it solves the

still very unhappy that the british swedish pharmaceutical company is in its words failing to deliver on the doses that it was contracted to do now e.u. leaders are very divided on the idea of these so-called of the so-called blocking of exports you have some e.u. politicians are saying look this is just the narrative it's all talk this is the commission basically trying to ramp up the rhetoric in order to put pressure on these pharmaceutical companies to deliver their doses some e.u. leaders only countries france italy for example that are really backing these 2nd waves a 3rd waves i should say release of. the idea of these export blocks other countries netherlands germany far more cautious they certainly don't want the to become embroiled in any form of. ok so there is no chance in paris with the european side of things thank you natasha we cross the channel now reach chalons in brighton in the u.k. with this peculiar situation i guess rory with the u.k. could almost in their eyes get see themselves being punished for doing so well with their vaccination rollout. yeah i mean the per

because pharmaceutical companies including british swedish giant astra zeneca had failed to deliver the promised doses e.u. council headshell michel said the blocks priority now was boosting the vaccine rollout if you used the urgent imperative is to queue porking in europe to improve the production and distribution of stored member states that is the priority we are totally mobilized the rising cost of it infections and deaths in many countries of put european governments under increased pressure several parts of france including paris are battling a 3rd wave the government has tightened restrictions but unless a ramps up its vaccine rollout some doctors say that the country could be heading into another national lock down one in 10 people in france has received a 1st coded vaccine dose compared to half of the u.k.'s population france's president said that the e.u. needs a fresh approach or purple for the i believe very deeply this is one of the lessons of the crisis for europe as for france we must drastically simplify our responses we are too slow we're too complex with you stuck in

companies that have promised doses to the e.u. must deliver those doses o'sullivan delay and the e.u. commission head said that the british swedish their master seneca had only delivered 30 percent of the 90000000 doses it had been contracted to deliver in the 1st quarter of this year said i made it very clear that pharmaceutical companies must must adhere to the commitments in their contracts they must deliver those doses but the question is what will the e.u. do if they do not because that was the question that she failed to answer because it is clear that e.u. leaders failed to unite behind a proposal that had been put forward by the commission to curb exports of covert vaccines the leaders have been pretty divided on this you know you get countries like italy and france who fully supported to say the pharmaceutical companies should face severe penalties if they do not fulfill their contracts but other countries like the netherlands germany belgium far more cautious they didn't want to be involved in what would be seen as vaccine warfare series appends on your perspective but some are saying that the e.u. in fact really failed

the british have priority to supplies from astrazeneca. the problem seems to be the angle-swedish companys signed two deals with the eu and u.k., which are not entirely compatible. the are trying to meet too much demand with inadequate supply. >> france accused the u.k. of blackmail over its handling of the coronavirus vaccine. is that strong or unfair perspective, coming from france -- or is that a fair perspective from france tonight? >> i think it is strong because the problem is that the u.k. did a better deal with astrazeneca, then the eu and they did it much earlier. so they have a head start, and, as we see from the figures, they have done quite well on getting vaccination off the ground. they are insisting -- they do not have any legal that on exports, of astrazeneca vaccinations, but they do have a contract that says they get it first and i think that is the problem. the british need to realize, and i think solidity are doing so, that they will also be in a very bad position, if infections take off across the european union, and the possibility, of the disease coming back into th

companies that have promised doses to the e.u. must deliver those doses o'sullivan delaying the commission head said that the british swedish for master seneca had only delivered 30 percent of the 90000000 doses it had been contracted to deliver in the 1st quarter of this year's have on delay and made it very clear that pharmaceutical companies must must adhere to the commitments in their contract they must deliver those doses but the question is what will the e.u. do if they do not because that was the question she failed to answer because it is clear that leaders failed to unite behind a proposal that had been put forward by the e.u. commission to curb exports of covert vaccines e.u. leaders have been pretty divided on this you know you have countries like italy and france who fully supported to say that pharmaceutical companies should face severe penalties if they do not fulfill their contracts but other countries like the netherlands germany belgium far more cautious they didn't want to be employed in what would be seen as vaccine warfare so agrees appends on your perspective but some are saying that the e.u. in fact really failed

british. it's the oxford university in collaboration with this angelo-swedish company, astrazeneca. it coincided with brexit. and then it turned out that in january, the european union -- the european commission had ordered way too few vaccines of all types, moderna and pfizer included. and that astrazeneca was unable to deliver as many as it had pledged to deliver. and so the real crisis that we're now seeing get worse, in fact, in europe, was exacerbated by astrazeneca's failure to deliver what it had pledged to deliver. we then had i think what now turns out to be exaggerated or unsubstantiated claims that astrazeneca could trigger blood clots and thrombosis and some death in people. it turns out that that isn't true. it isn't backed up by scientific evidence. it's anecdotal. but a number of countries, starting with germany, temporarily suspended astrazeneca, thereby making the shortage of vaccines in the slowness of europe's rollout even worse. now, the european medicine's agency, which is their equivalent of the fda, says it's perfectly safe to use. in britain, 17 million peopl